Investigational Site Number 4840005

Guadalajara 44650

0 studies enrolling now · 2 studies all time

What they study most

Systemic Sclerosis, Type 2 Diabetes Mellitus

Studies at this site

• Effectiveness and Safety of SAR156597 in Treating Diffuse Systemic Sclerosis — Completed
• Effect of Efpeglenatide on Cardiovascular Outcomes — Stopped early